{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:44:26Z","timestamp":1791254666621,"version":"4.1.0"},"reference-count":144,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T00:00:00Z","timestamp":1758326400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["General Hospital Psychiatry"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.genhosppsych.2025.09.003","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T21:11:13Z","timestamp":1758057073000},"page":"11-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Key competencies for psychedelic treatment in real-world mental health care settings"],"prefix":"10.1016","volume":"97","author":[{"given":"Max","family":"Wolff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Rutrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Gr\u00fcnder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Jungaberle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Jungaberle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.genhosppsych.2025.09.003_bb0005","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1007\/s00213-024-06620-x","article-title":"Psychedelic-assisted psychotherapy: where is the psychotherapy research?","volume":"241","author":"Aday","year":"2024","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.09.003_bb0010","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1186\/s12909-025-06871-y","article-title":"Further education in psychedelic-assisted therapy \u2013 experiences from Switzerland","volume":"25","author":"Aicher","year":"2025","journal-title":"BMC Med Educ"},{"issue":"8","key":"10.1016\/j.genhosppsych.2025.09.003_bb0015","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1080\/09540261.2024.2410853","article-title":"Psychedelic therapy \u2013 refining the claim of a paradigm shift","volume":"36","author":"Aicher","year":"2024","journal-title":"Int Rev Psychiatry"},{"issue":"3","key":"10.1016\/j.genhosppsych.2025.09.003_bb0020","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3949\/ccjm.92a.24032","article-title":"Psychedelic-assisted therapy: an overview for the internist","volume":"92","author":"Barnett","year":"2025","journal-title":"Cleve Clin J Med"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.09.003_bb0025","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00213-024-06722-6","article-title":"Practical considerations in the establishment of psychedelic research programs","volume":"242","author":"Barnett","year":"2025","journal-title":"Psychopharmacology"},{"issue":"12","key":"10.1016\/j.genhosppsych.2025.09.003_bb0030","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1177\/0269881116678781","article-title":"The challenging experience questionnaire: characterization of challenging experiences with psilocybin mushrooms","volume":"30","author":"Barrett","year":"2016","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0035","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.3389\/fpsyg.2017.01238","article-title":"Qualitative and quantitative features of music reported to support peak mystical experiences during psychedelic therapy sessions","volume":"8","author":"Barrett","year":"2017","journal-title":"Front Psychol"},{"issue":"7","key":"10.1016\/j.genhosppsych.2025.09.003_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0253779","article-title":"Altered states phenomena induced by visual flicker light stimulation","volume":"16","author":"Bartossek","year":"2021","journal-title":"PloS One"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2022.824077","article-title":"Psychedelic integration: an analysis of the concept and its practice","volume":"13","author":"Bathje","year":"2022","journal-title":"Front Psychol"},{"issue":"6","key":"10.1016\/j.genhosppsych.2025.09.003_bb0050","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1177\/070674370404900605","article-title":"Psychotherapeutic interventions at the end of life: a focus on meaning and spirituality","volume":"49","author":"Breitbart","year":"2004","journal-title":"Can J Psychiatry"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.09.003_bb0055","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s44184-024-00095-6","article-title":"A qualitative analysis of the psychedelic mushroom come-up and come-down","volume":"4","author":"Brouwer","year":"2025","journal-title":"Npj Mental Health Research"},{"issue":"4","key":"10.1016\/j.genhosppsych.2025.09.003_bb0060","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1177\/0269881120959637","article-title":"Pivotal mental states","volume":"35","author":"Brouwer","year":"2021","journal-title":"J Psychopharmacol"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.09.003_bb0065","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/PRS.0b013e318219c171","article-title":"The levels of evidence and their role in evidence-based medicine","volume":"128","author":"Burns","year":"2011","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2022.1020222","article-title":"Commentary: psychedelics and psychotherapy: cognitive-behavioral approaches as default","volume":"13","author":"Burton","year":"2022","journal-title":"Front Psychol"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0075","series-title":"Traumatic psychedelic experiences","author":"Calder","year":"2025"},{"issue":"3","key":"10.1016\/j.genhosppsych.2025.09.003_bb0080","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1124\/pr.118.017160","article-title":"REBUS and the anarchic brain: toward a unified model of the brain action of psychedelics","volume":"71","author":"Carhart-Harris","year":"2019","journal-title":"Pharmacol Rev"},{"issue":"7","key":"10.1016\/j.genhosppsych.2025.09.003_bb0085","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1177\/0269881118754710","article-title":"Psychedelics and the essential importance of context","volume":"32","author":"Carhart-Harris","year":"2018","journal-title":"J Psychopharmacol"},{"issue":"2","key":"10.1016\/j.genhosppsych.2025.09.003_bb0090","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/j.2161-007X.2007.tb00071.x","article-title":"The only way out is through: the peril of spiritual bypass","volume":"51","author":"Cashwell","year":"2007","journal-title":"Couns Values"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0095","series-title":"Becoming better psychotherapists: Advancing training and supervision","year":"2023"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2022.887255","article-title":"Psychedelic-assisted psychotherapy\u2014a systematic review of associated psychological interventions","volume":"13","author":"Cavarra","year":"2022","journal-title":"Front Psychol"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0105","author":"Central Institute for Mental Health"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.09.003_bb0110","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1080\/15265161.2024.2433421","article-title":"Distinctive but not exceptional: the risks of psychedelic ethical exceptionalism","volume":"25","author":"Cheung","year":"2025","journal-title":"Am J Bioeth"},{"issue":"8","key":"10.1016\/j.genhosppsych.2025.09.003_bb0115","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1080\/09540261.2024.2357678","article-title":"Psychedelic group-based integration: ethical assessment and initial recommendations","volume":"36","author":"Cheung","year":"2024","journal-title":"Int Rev Psychiatry"},{"issue":"12","key":"10.1016\/j.genhosppsych.2025.09.003_bb0120","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.3390\/rel12121058","article-title":"Psychedelic epistemology: William James and the \u201cnoetic quality\u201d of mystical experience","volume":"12","author":"Cole-Turner","year":"2021","journal-title":"Religions"},{"issue":"11","key":"10.1016\/j.genhosppsych.2025.09.003_bb0125","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/jamapsychiatry.2024.2887","article-title":"The psychotherapy in MDMA-assisted psychotherapy","volume":"81","author":"Cristea","year":"2024","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.09.003_bb0130","doi-asserted-by":"crossref","first-page":"16524","DOI":"10.1038\/s41598-024-66817-0","article-title":"Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapy","volume":"14","author":"De La Salle","year":"2024","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.genhosppsych.2025.09.003_bb0135","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1037\/a0023889","article-title":"Starting off on the right foot: common factor elements in early psychotherapy process","volume":"21","author":"DeFife","year":"2011","journal-title":"Journal of Psychotherapy Integration"},{"issue":"11","key":"10.1016\/j.genhosppsych.2025.09.003_bb0140","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s40265-024-02106-4","article-title":"How psychedelics modulate multiple memory mechanisms in posttraumatic stress disorder","volume":"84","author":"Doss","year":"2024","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.genhosppsych.2025.09.003_bb0145","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1037\/rev0000455","article-title":"Unique effects of sedatives, dissociatives, psychedelics, stimulants, and cannabinoids on episodic memory: a review and reanalysis of acute drug effects on recollection, familiarity, and metamemory","volume":"131","author":"Doss","year":"2024","journal-title":"Psychol Rev"},{"issue":"2","key":"10.1016\/j.genhosppsych.2025.09.003_bb0150","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1215\/00382876-11626609","article-title":"History of psychedelics: an overview","volume":"124","author":"Dyck","year":"2025","journal-title":"South Atlantic Quarterly"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0155","series-title":"Psychedelic humanities","author":"Dyck","year":"2024"},{"issue":"4","key":"10.1016\/j.genhosppsych.2025.09.003_bb0160","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1089\/psymed.2023.0058","article-title":"The role of music in psychedelic-assisted therapy: a comparative analysis of neuroscientific research, indigenous Entheogenic ritual, and contemporary care models","volume":"2","author":"Efthimiou","year":"2024","journal-title":"Psychedelic Medicine"},{"issue":"4","key":"10.1016\/j.genhosppsych.2025.09.003_bb0165","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1017\/S0963180123000099","article-title":"Is the requirement for first-person experience of psychedelic drugs a justified component of a psychedelic therapist\u2019s training?","volume":"33","author":"Emmerich","year":"2024","journal-title":"Camb Q Healthc Ethics"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.09.003_bb0170","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1176\/appi.prcp.20240128","article-title":"On minimizing risk and harm in the use of psychedelics","volume":"7","author":"Evans","year":"2025","journal-title":"Psychiatric Research and Clinical Practice"},{"issue":"10","key":"10.1016\/j.genhosppsych.2025.09.003_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0293349","article-title":"Extended difficulties following the use of psychedelic drugs: a mixed methods study","volume":"18","author":"Evans","year":"2023","journal-title":"PloS One"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0180","series-title":"The Inner Healer and the Inner Critic","author":"Evans","year":"2024"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0185","article-title":"In psychedelic-assisted therapy, the alliance in the psychotherapy component is as important as the drug","volume":"1\u20135","author":"Fl\u00fcckiger","year":"2025","journal-title":"Psychother Psychosom"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2025.106178","article-title":"Classification schemes of altered states of consciousness","volume":"175","author":"Fort","year":"2025","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0195","series-title":"Man\u2019s search for meaning","author":"Frankl","year":"1985"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2022.863247","article-title":"The psychedelic integration scales: tools for measuring psychedelic integration behaviors and experiences","volume":"13","author":"Frymann","year":"2022","journal-title":"Front Psychol"},{"issue":"4","key":"10.1016\/j.genhosppsych.2025.09.003_bb0205","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/09540261.2018.1486289","article-title":"Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions","volume":"30","author":"Garcia-Romeu","year":"2018","journal-title":"Int Rev Psychiatry"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0210","article-title":"The Montreal model: an integrative biomedical-psychedelic approach to ketamine for severe treatment-resistant depression","volume":"14","author":"Garel","year":"2023","journal-title":"Front Psych"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.09.003_bb0215","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1176\/appi.ajp.20230914","article-title":"Primum non Nocere: the onus to characterize the potential harms of psychedelic treatment","volume":"182","author":"Ghaznavi","year":"2025","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0220","series-title":"Disruptive psychopharmacology","first-page":"35","article-title":"Effects of setting on psychedelic experiences, therapies, and outcomes: A rapid scoping review of the literature","volume":"vol. 56","author":"Golden","year":"2022"},{"issue":"4","key":"10.1016\/j.genhosppsych.2025.09.003_bb0225","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1037\/amp0000365","article-title":"Obtaining consensus in psychotherapy: what holds us back?","volume":"74","author":"Goldfried","year":"2019","journal-title":"Am Psychol"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.09.003_bb0230","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1176\/appi.ajp.20221043","article-title":"Must psilocybin always \u201cassist psychotherapy\u201d?","volume":"181","author":"Goodwin","year":"2024","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0235","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2021.645246","article-title":"Psychedelic harm reduction and integration: a Transtheoretical model for clinical practice","volume":"12","author":"Gorman","year":"2021","journal-title":"Front Psychol"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.09.003_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10503309712331331843","article-title":"Research-informed psychotherapy","volume":"7","author":"Grawe","year":"1997","journal-title":"Psychother Res"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0245","series-title":"Psychological therapy","author":"Grawe","year":"2002"},{"issue":"6","key":"10.1016\/j.genhosppsych.2025.09.003_bb0250","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1080\/17512433.2020.1772054","article-title":"Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments","volume":"13","author":"Greenway","year":"2020","journal-title":"Expert Review of Clinical Pharmacology"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0255","series-title":"Handbook of medical hallucinogens","year":"2022"},{"issue":"3","key":"10.1016\/j.genhosppsych.2025.09.003_bb0260","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S2215-0366(23)00363-2","article-title":"Treatment with psychedelics is psychotherapy: beyond reductionism","volume":"11","author":"Gr\u00fcnder","year":"2024","journal-title":"Lancet Psychiatry"},{"issue":"04","key":"10.1016\/j.genhosppsych.2025.09.003_bb0265","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/a-1486-7386","article-title":"The potential role of psychedelic drugs in mental health Care of the Future","volume":"54","author":"Gr\u00fcnder","year":"2021","journal-title":"Pharmacopsychiatry"},{"issue":"5","key":"10.1016\/j.genhosppsych.2025.09.003_bb0270","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1177\/1363461520983684","article-title":"Psychedelics, placebo effects, and set and setting: insights from common factors theory of psychotherapy","volume":"59","author":"Gukasyan","year":"2022","journal-title":"Transcult Psychiatry"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0275","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3389\/fphar.2018.00897","article-title":"Predicting responses to psychedelics: a prospective study","volume":"9","author":"Haijen","year":"2018","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.09.003_bb0280","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/01421599979969","article-title":"Outcome-based education: part 1-an introduction to outcome-based education","volume":"21","author":"Harden","year":"1999","journal-title":"Med Teach"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0285","doi-asserted-by":"crossref","DOI":"10.1177\/2050324516683325","article-title":"Constructing drug effects: a history of set and setting","volume":"3","author":"Hartogsohn","year":"2017","journal-title":"Drug Science, Policy and Law"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0290","series-title":"Set and setting for psychedelic harm reduction","author":"Hartogsohn","year":"2024"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.09.003_bb0295","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s44271-025-00247-0","article-title":"Decreased CO2 saturation during circular breathwork supports emergence of altered states of consciousness","volume":"3","author":"Havenith","year":"2025","journal-title":"Communications Psychology"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0300","doi-asserted-by":"crossref","DOI":"10.1556\/2054.2025.00436","article-title":"T\u016b Wairua: development of an indigenous Rongo\u0101 M\u0101ori approach to healing with psilocybin containing mushrooms","author":"Hodge","year":"2025","journal-title":"Journal of Psychedelic Studies"},{"issue":"2","key":"10.1016\/j.genhosppsych.2025.09.003_bb0305","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/1468-4446.12255","article-title":"Value orientations and social attitudes in the holistic milieu","volume":"68","author":"H\u00f6llinger","year":"2017","journal-title":"Br J Sociol"},{"issue":"6","key":"10.1016\/j.genhosppsych.2025.09.003_bb0310","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/s41386-022-01297-2","article-title":"Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects","volume":"47","author":"Holze","year":"2022","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.genhosppsych.2025.09.003_bb0315","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1176\/appi.psychotherapy.20200055","article-title":"Systematized review of psychotherapeutic components of psilocybin-assisted psychotherapy","volume":"74","author":"Horton","year":"2021","journal-title":"Am J Psychother"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.09.003_bb0320","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41380-021-01200-3","article-title":"Treatment resistance in psychiatry: state of the art and new directions","volume":"27","author":"Howes","year":"2022","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0325","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2023.1108333","article-title":"Transformative experience and informed consent to psychedelic-assisted psychotherapy","volume":"14","author":"Jacobs","year":"2023","journal-title":"Front Psychol"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.09.003_bb0330","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12152-023-09536-z","article-title":"When the trial ends: the case for post-trial provisions in clinical psychedelic research","volume":"17","author":"Jacobs","year":"2024","journal-title":"Neuroethics"},{"issue":"6","key":"10.1016\/j.genhosppsych.2025.09.003_bb0335","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/0269881108093587","article-title":"Human hallucinogen research: guidelines for safety","volume":"22","author":"Johnson","year":"2008","journal-title":"J Psychopharmacol"},{"issue":"2","key":"10.1016\/j.genhosppsych.2025.09.003_bb0340","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1021\/acsptsci.0c00198","article-title":"Consciousness, religion, and gurus: pitfalls of psychedelic medicine","volume":"4","author":"Johnson","year":"2021","journal-title":"ACS Pharmacology & Translational Science"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0345","series-title":"Handbook of medical hallucinogens","first-page":"363","article-title":"The use of music in psychedelic therapy","author":"Kaelen","year":"2021"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0350","doi-asserted-by":"crossref","DOI":"10.1007\/s00213-025-06771-5","article-title":"Psychedelics and autobiographical memory \u2013 six open questions","author":"Kangaslampi","year":"2025","journal-title":"Psychopharmacology"},{"issue":"8","key":"10.1016\/j.genhosppsych.2025.09.003_bb0355","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1080\/09540261.2024.2419662","article-title":"Beyond psychedelics: set and setting in general psychiatric practice","volume":"36","author":"Kozak","year":"2024","journal-title":"Int Rev Psychiatry"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0360","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2025.6261","article-title":"Improving patients\u2019 treatment expectations","author":"Laferton","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0365","series-title":"Philosophy of psychedelics","author":"Letheby","year":"2021"},{"issue":"3","key":"10.1016\/j.genhosppsych.2025.09.003_bb0370","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/wps.20654","article-title":"What is \u201cevidence\u201d in psychotherapies?","volume":"18","author":"Lilienfeld","year":"2019","journal-title":"World Psychiatry"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.09.003_bb0375","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1089\/psymed.2023.0033","article-title":"Getting in touch with touch: the importance of studying touch in MDMA-assisted therapy and the development of a new self-report measure","volume":"2","author":"Luoma","year":"2024","journal-title":"Psychedelic Medicine"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpra.2025.02.002","article-title":"Utilizing in vivo and imaginal exposure in the context of MDMA-assisted therapy for social anxiety disorder: a case report","author":"Luoma","year":"2025","journal-title":"Cogn Behav Pract"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.09.003_bb0385","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/15265161.2024.2433425","article-title":"From theory to practice: the importance of operationalizing and measuring ethical touch in psychedelic-assisted therapy","volume":"25","author":"Luoma","year":"2025","journal-title":"Am J Bioeth"},{"issue":"4","key":"10.1016\/j.genhosppsych.2025.09.003_bb0390","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1177\/21677026221133034","article-title":"The memory wars then and now: the contributions of Scott O. Lilienfeld","volume":"11","author":"Lynn","year":"2023","journal-title":"Clin Psychol Sci"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpra.2025.02.001","article-title":"A case study of the METEMP protocol: massed exposure therapy enhanced with 3,4-Methylenedioxymethamphetamine (MDMA) for posttraumatic stress disorder","author":"Maples-Keller","year":"2025","journal-title":"Cogn Behav Pract"},{"issue":"6","key":"10.1016\/j.genhosppsych.2025.09.003_bb0400","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1001\/jamapsychiatry.2024.0184","article-title":"Essentials of informed consent to psychedelic medicine","volume":"81","author":"Marks","year":"2024","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.09.003_bb0405","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s44271-024-00120-6","article-title":"An integrated theory of false insights and beliefs under psychedelics","volume":"2","author":"McGovern","year":"2024","journal-title":"Communications Psychology"},{"issue":"6","key":"10.1016\/j.genhosppsych.2025.09.003_bb0410","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.14650","article-title":"Developing an ethics and policy framework for psychedelic clinical care: a consensus statement","volume":"7","author":"McGuire","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0415","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2022.873455","article-title":"Music programming for psilocybin-assisted therapy: guided imagery and music-informed perspectives","volume":"13","author":"Messell","year":"2022","journal-title":"Front Psychol"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0420","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jad.2023.01.077","article-title":"Optimizing outcomes in psilocybin therapy: considerations in participant evaluation and preparation","volume":"326","author":"Modlin","year":"2023","journal-title":"J Affect Disord"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.09.003_bb0425","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/19012276.2020.1762713","article-title":"Personal therapy and the personal therapist","volume":"73","author":"Moe","year":"2021","journal-title":"Nordic Psychology"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0430","doi-asserted-by":"crossref","DOI":"10.1177\/20451253251381074","article-title":"Psychedelic Assisted Therapy as a Complex Intervention: Implications for clinical trial design","author":"Muthukumaraswamy","year":"2025","journal-title":"Therapeutic Advances in Psychopharmacology"},{"issue":"7966","key":"10.1016\/j.genhosppsych.2025.09.003_bb0435","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/s41586-023-06204-3","article-title":"Psychedelics reopen the social reward learning critical period","volume":"618","author":"Nardou","year":"2023","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.09.003_bb0440","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/15265161.2024.2433428","article-title":"Supportive touch in psychedelic assisted therapy","volume":"25","author":"Neitzke-Spruill","year":"2025","journal-title":"Am J Bioeth"},{"issue":"04","key":"10.1016\/j.genhosppsych.2025.09.003_bb0445","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1055\/a-1310-3990","article-title":"The history of psychedelics in psychiatry","volume":"54","author":"Nichols","year":"2021","journal-title":"Pharmacopsychiatry"},{"issue":"2","key":"10.1016\/j.genhosppsych.2025.09.003_bb0450","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1556\/2054.2018.009","article-title":"The influence of therapists\u2019 first-hand experience with psychedelics on psychedelic-assisted psychotherapy research and therapist training","volume":"2","author":"Nielson","year":"2018","journal-title":"Journal of Psychedelic Studies"},{"issue":"13","key":"10.1016\/j.genhosppsych.2025.09.003_bb0455","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1017\/S0033291723001289","article-title":"Dark loops: contagion effects, consistency and chemosocial matrices in psychedelic-assisted therapy trials","volume":"53","author":"Noorani","year":"2023","journal-title":"Psychol Med"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0460","article-title":"The Australia story: current status and future challenges for the clinical applications of psychedelics","volume":"bph.17398","author":"Nutt","year":"2024","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0465","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2024.1427531","article-title":"The conceptual framework for the therapeutic approach used in phase 3 trials of MDMA-assisted therapy for PTSD","volume":"15","author":"O\u2019Donnell","year":"2024","journal-title":"Front Psychol"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0470","article-title":"Using a MDMA- and LSD-group therapy model in clinical practice in Switzerland and highlighting the treatment of trauma-related disorders","volume":"13","author":"Oehen","year":"2022","journal-title":"Front Psych"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.09.003_bb0475","first-page":"2","article-title":"\u00abLearning from many masters\u00bb: Ans\u00e4tze zu einer wissenschaftlichen Integration psychotherapeutischer Behandlungsmodelle","volume":"39","author":"Orlinsky","year":"1994","journal-title":"Psychotherapeut (Berlin)"},{"issue":"7","key":"10.1016\/j.genhosppsych.2025.09.003_bb0480","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jamapsychiatry.2023.1554","article-title":"Importance of integrating spiritual, existential, religious, and theological components in psychedelic-assisted therapies","volume":"80","author":"Palitsky","year":"2023","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0485","article-title":"Lower-dose psycholytic therapy \u2013 a neglected approach","volume":"13","author":"Passie","year":"2022","journal-title":"Front Psych"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.09.003_bb0490","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0296071","article-title":"Spiritual health practitioners\u2019 contributions to psychedelic assisted therapy: a qualitative analysis","volume":"19","author":"Peacock","year":"2024","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.09.003_bb0495","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s40337-025-01274-2","article-title":"Therapeutic emergence of dissociated traumatic memories during psilocybin treatment for anorexia nervosa","volume":"13","author":"Peck","year":"2025","journal-title":"J Eat Disord"},{"issue":"5","key":"10.1016\/j.genhosppsych.2025.09.003_bb0500","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1177\/02698811241239206","article-title":"Psychedelics and the \u2018inner healer\u2019: myth or mechanism?","volume":"38","author":"Peill","year":"2024","journal-title":"J Psychopharmacol"},{"issue":"5","key":"10.1016\/j.genhosppsych.2025.09.003_bb0505","doi-asserted-by":"crossref","DOI":"10.1177\/0022167817711304","article-title":"Developing guidelines and competencies for the training of psychedelic therapists","volume":"57","author":"Phelps","year":"2017","journal-title":"Journal of Humanistic Psychology"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.09.003_bb0510","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12954-021-00489-1","article-title":"Ethical and legal issues in psychedelic harm reduction and integration therapy","volume":"18","author":"Pilecki","year":"2021","journal-title":"Harm Reduct J"},{"issue":"7","key":"10.1016\/j.genhosppsych.2025.09.003_bb0515","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1177\/02698811231155117","article-title":"Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factors","volume":"37","author":"Ponomarenko","year":"2023","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0520","series-title":"Ethical aspects of psychedelic-assisted treatments: an overview","author":"Poppe","year":"2024"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.09.003_bb0525","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12152-025-09596-3","article-title":"Mitigating ethical issues in training for psychedelic therapy","volume":"18","author":"Poppe","year":"2025","journal-title":"Neuroethics"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0530","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-025-03685-9","article-title":"An international Delphi consensus for reporting of setting in psychedelic clinical trials","author":"Pronovost-Morgan","year":"2025","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.genhosppsych.2025.09.003_bb0535","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1177\/02698811231182602","article-title":"Harnessing placebo: lessons from psychedelic science","volume":"37","author":"Pronovost-Morgan","year":"2023","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0540","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2024.1369715","article-title":"Coming back together: a qualitative survey study of coping and support strategies used by people to cope with extended difficulties after the use of psychedelic drugs","volume":"15","author":"Robinson","year":"2024","journal-title":"Front Psychol"},{"issue":"3","key":"10.1016\/j.genhosppsych.2025.09.003_bb0545","doi-asserted-by":"crossref","DOI":"10.1037\/cap0000285","article-title":"Entheogens and psychedelics in Canada: proposal for a new paradigm","volume":"63","author":"Rochester","year":"2022","journal-title":"Canadian Psychology \/ Psychologie Canadienne"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0550","series-title":"Client-centered therapy: Its current practice, implications, and theory","author":"Rogers","year":"1965"},{"issue":"9","key":"10.1016\/j.genhosppsych.2025.09.003_bb0555","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1177\/0269881119855974","article-title":"Emotional breakthrough and psychedelics: validation of the emotional breakthrough inventory","volume":"33","author":"Roseman","year":"2019","journal-title":"J Psychopharmacol"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.09.003_bb0560","doi-asserted-by":"crossref","DOI":"10.1093\/nc\/niae038","article-title":"On the varieties of conscious experiences: altered beliefs under psychedelics (ALBUS)","volume":"2025","author":"Safron","year":"2025","journal-title":"Neuroscience of Consciousness"},{"issue":"2","key":"10.1016\/j.genhosppsych.2025.09.003_bb0565","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.70097","article-title":"From efficacy to effectiveness: evaluating psychedelic randomized controlled trials for trustworthy evidence-based policy and practice","volume":"13","author":"Schenberg","year":"2025","journal-title":"Pharmacol Res Perspect"},{"issue":"10","key":"10.1016\/j.genhosppsych.2025.09.003_bb0570","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1080\/14737175.2023.2246655","article-title":"Adapting psychedelic medicine for headache and chronic pain disorders","volume":"23","author":"Schindler","year":"2023","journal-title":"Expert Rev Neurother"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.09.003_bb0575","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S2215-0366(24)00333-X","article-title":"Quality of reporting on psychological interventions in psychedelic treatments: a systematic review","volume":"12","author":"Seybert","year":"2025","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0580","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jcbs.2019.11.002","article-title":"Psilocybin-assisted therapy of major depressive disorder using acceptance and commitment therapy as a therapeutic frame","volume":"15","author":"Sloshower","year":"2020","journal-title":"J Contextual Behav Sci"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0585","series-title":"Visions in psychotherapy research and practice: Reflections from the presidents of the society for psychotherapy research","author":"Strauss","year":"2015"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.09.003_bb0590","doi-asserted-by":"crossref","DOI":"10.1002\/cpp.2945","article-title":"Therapeutic frameworks in integration sessions in substance-assisted psychotherapy: a systematised review","volume":"31","author":"Thal","year":"2024","journal-title":"Clin Psychol Psychother"},{"issue":"11","key":"10.1016\/j.genhosppsych.2025.09.003_bb0595","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1177\/02698811221127954","article-title":"Therapeutic (sub)stance: current practice and therapeutic conduct in preparatory sessions in substance-assisted psychotherapy\u2014a systematized review","volume":"36","author":"Thal","year":"2022","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0600","doi-asserted-by":"crossref","DOI":"10.1177\/00221678231168516","article-title":"Dosing and therapeutic conduct in administration sessions in substance-assisted psychotherapy: a systematized review","author":"Thal","year":"2023","journal-title":"Journal of Humanistic Psychology"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0605","series-title":"Curriculum development for medical education: A six-step approach","author":"Thomas","year":"2022"},{"issue":"5","key":"10.1016\/j.genhosppsych.2025.09.003_bb0610","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1177\/13634615221082796","article-title":"Towards psychedelic apprenticeship: developing a gentle touch for the mediation and validation of psychedelic-induced insights and revelations","volume":"59","author":"Timmermann","year":"2022","journal-title":"Transcult Psychiatry"},{"issue":"6","key":"10.1016\/j.genhosppsych.2025.09.003_bb0615","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1177\/0269881115581980","article-title":"European rating of drug harms","volume":"29","author":"Van Amsterdam","year":"2015","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0620","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.genhosppsych.2025.06.003","article-title":"Patient\u2013therapist relationship in psychedelic-assisted therapy: implications for future real-world settings","volume":"96","author":"Villiger","year":"2025","journal-title":"Gen Hosp Psychiatry"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.09.003_bb0625","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/ejsp.2721","article-title":"An exploration of spiritual superiority: the paradox of self-enhancement","volume":"51","author":"Vonk","year":"2021","journal-title":"Eur J Soc Psychol"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.09.003_bb0630","doi-asserted-by":"crossref","first-page":"28022","DOI":"10.1038\/s41598-024-78736-1","article-title":"Knowledge, attitudes, and concerns about psilocybin and MDMA as novel therapies among U.S. healthcare professionals","volume":"14","author":"Wang","year":"2024","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.09.003_bb0635","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/13537903.2011.539846","article-title":"The emergence of Conspirituality","volume":"26","author":"Ward","year":"2011","journal-title":"Journal of Contemporary Religion"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0640","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jcbs.2019.12.004","article-title":"The use of the psychological flexibility model to support psychedelic assisted therapy","volume":"15","author":"Watts","year":"2020","journal-title":"J Contextual Behav Sci"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.09.003_bb0645","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1556\/2054.2023.00294","article-title":"Perceptions and attitudes towards psychedelic-assisted psychotherapy among health professionals, patients, and the public: a systematic review","volume":"8","author":"Wells","year":"2024","journal-title":"Journal of Psychedelic Studies"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0650","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fpsyt.2020.00005","article-title":"Learning to let go: a cognitive-behavioral model of how psychedelic therapy promotes acceptance","volume":"11","author":"Wolff","year":"2020","journal-title":"Front Psych"},{"issue":"5","key":"10.1016\/j.genhosppsych.2025.09.003_bb0655","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1177\/02698811241249698","article-title":"Measuring psychotherapeutic processes in the context of psychedelic experiences: validation of the general change mechanisms questionnaire (GCMQ)","volume":"38","author":"Wolff","year":"2024","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0660","doi-asserted-by":"crossref","DOI":"10.1177\/20503245251348272","article-title":"Reframing psychedelic regulation: tools, not treatments","volume":"11","author":"Wolff","year":"2025","journal-title":"Drug Science, Policy and Law"},{"issue":"3","key":"10.1016\/j.genhosppsych.2025.09.003_bb0665","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/02698811211073758","article-title":"The acceptance\/avoidance-promoting experiences questionnaire (APEQ): a theory-based approach to psychedelic drugs\u2019 effects on psychological flexibility","volume":"36","author":"Wolff","year":"2022","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0670","doi-asserted-by":"crossref","DOI":"10.1037\/rev0000589","article-title":"Common factors in altered states: understanding psychedelic therapy through the lens of Grawe\u2019s general change mechanisms","author":"Wolff","year":"2025","journal-title":"Psychol Rev"},{"issue":"4","key":"10.1016\/j.genhosppsych.2025.09.003_bb0675","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1080\/10503301003796839","article-title":"Goal setting in psychotherapy: the relevance of approach and avoidance goals for treatment outcome","volume":"20","author":"Wollburg","year":"2010","journal-title":"Psychother Res"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.09.003_bb0680","doi-asserted-by":"crossref","first-page":"28817","DOI":"10.1038\/s41598-024-79931-w","article-title":"Strategies for resolving challenging psychedelic experiences: insights from a mixed-methods study","volume":"14","author":"Wood","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0685","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2022.873279","article-title":"Psychedelics and psychotherapy: cognitive-behavioral approaches as default","volume":"13","author":"Yaden","year":"2022","journal-title":"Front Psychol"},{"issue":"9","key":"10.1016\/j.genhosppsych.2025.09.003_bb0690","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/s44159-024-00345-6","article-title":"Clinically relevant acute subjective effects of psychedelics beyond mystical experience","volume":"3","author":"Yaden","year":"2024","journal-title":"Nature Reviews Psychology"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.09.003_bb0695","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/psymed.2024.0019","article-title":"A field-wide review and analysis of study materials used in psilocybin trials: assessment of two decades of research","volume":"3","author":"Yaden","year":"2025","journal-title":"Psychedelic Medicine"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0700","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780192898371.003.0008","article-title":"Belief change and agnostic frames in psychedelic research and clinical contexts","volume":"166","author":"Yaden","year":"2024","journal-title":"Philosophical perspectives on psychedelic Psychiatry"},{"issue":"5","key":"10.1016\/j.genhosppsych.2025.09.003_bb0705","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/jamapsychiatry.2020.3672","article-title":"Psychedelics in psychiatry\u2014keeping the renaissance from going off the rails","volume":"78","author":"Yaden","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0710","series-title":"Existential psychotherapy","author":"Yalom","year":"2020"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.09.003_bb0715","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/15265161.2024.2433418","article-title":"From safe touch to sexual abuse: walking the tightrope of patient safety in psychedelic therapy","volume":"25","author":"Yang","year":"2025","journal-title":"Am J Bioeth"},{"key":"10.1016\/j.genhosppsych.2025.09.003_bb0720","article-title":"Psychedelic therapy in the treatment of addiction: the past, present and future","volume":"14","author":"Zafar","year":"2023","journal-title":"Front Psych"}],"container-title":["General Hospital Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834325001823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834325001823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:52:29Z","timestamp":1785862349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163834325001823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":144,"alternative-id":["S0163834325001823"],"URL":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2025.09.003","relation":{},"ISSN":["0163-8343"],"issn-type":[{"value":"0163-8343","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Key competencies for psychedelic treatment in real-world mental health care settings","name":"articletitle","label":"Article Title"},{"value":"General Hospital Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2025.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}